# Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

> **NCT07212426** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Longbio Pharma** · enrollment: 30 (actual)

## Conditions studied

- PNH - Paroxysmal Nocturnal Hemoglobinuria

## Interventions

- **BIOLOGICAL:** LP-005 Injection

## Key facts

- **NCT ID:** NCT07212426
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2026-05-06
- **Final completion:** 2028-03-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212426, "Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07212426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*